← Back to Search

Telemedicine Assessments for Autism

N/A

Recruiting

Led By Zachary Warren, Ph.D.

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 years or older

Child between 18 and 42 months of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and six-month follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare the use of a telemedicine tool to assess for autism symptoms in toddlers with gold standard, in-person ASD assessments.

Who is the study for?

This trial is for parents or guardians of toddlers aged 18-42 months who may have autism. Participants must be over 18, speak English well enough to follow the study procedures, live within a 3-hour drive from the study sites, and have access to technology with internet and audio-visual capabilities for tele-assessment.

What is being tested?

The study is testing a telemedicine tool called TELE-ASD-PEDS (TAP) designed for assessing autism symptoms in toddlers at home. It compares the effectiveness of TAP assessments done remotely with traditional in-person evaluations.

What are the potential side effects?

Since this trial involves assessment tools rather than medical treatments, there are no direct physical side effects. However, participants might experience inconvenience or stress related to using new technology or due to the time commitment required.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My child is between 18 and 42 months old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and six-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and six-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and six-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Diagnostic accuracy of the TAP

Validity of the TAP

Secondary study objectives

Child service access and utilization

Family empowerment

Family perceptions of tele-assessment

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Tele-assessment + in-person assessmentExperimental Treatment1 Intervention

Participants in this group will receive a tele-assessment using the TAP and will attend a traditional, in-person evaluation for autism spectrum disorder in a clinic setting.

Group II: Tele-assessment onlyActive Control1 Intervention

Participants in this group will receive a tele-assessment using the TAP, followed by a second, shorter tele-assessment.

0 / 2Eligibility criteria met